Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
about
Breast cancer and sentinel lymph node micrometastases: indications for lymphadenectomy and literature reviewPartial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancerFactors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.Histological examination of sentinel lymph nodes: significance of macrometastasis, micrometastasis, and isolated tumor cells.Two decades of axillary management in breast cancer.Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure.A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era.Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy.A logistic regression model predicting high axillary tumour burden in early breast cancer patients.Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients
P2860
Q35063285-E2899ED2-4F0A-431E-BF82-8C4C2644590EQ35677986-5F3C2B20-3145-4BF9-89D1-592EAD0870F5Q36734707-B07389E3-D50B-4AD6-883B-3CF5DB3A4BD7Q37337074-E3AF3CE2-247D-498B-9C30-EE01CE63152AQ38348404-07517B79-F7CB-41AD-9C2E-80DD70CADFDAQ38928989-0211CA87-2589-4486-BD78-B52DC7D2265DQ39838018-47133686-6F09-43E4-B7C9-88979B85920EQ40143160-7C224BCE-EE44-4875-B783-ACF84BD00A2EQ40682734-8F09592B-4C68-4AD5-9497-70441BD9EEC0Q41026255-A49E6283-01E2-4050-A064-599A69BEDE02Q42153163-915CBE29-BC1C-479F-8C09-2CDAFDE971A3Q48238273-CAECE035-0B65-4165-9EE1-B98135219EC0Q55070760-262F5F69-8AA9-42D3-B095-2330900BB354Q57108491-8D99D8DD-7A7F-4879-A048-932473BAC0CD
P2860
Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Which sentinel lymph-node (SLN ...... OSOG Z0011 results and beyond.
@en
type
label
Which sentinel lymph-node (SLN ...... OSOG Z0011 results and beyond.
@en
prefLabel
Which sentinel lymph-node (SLN ...... OSOG Z0011 results and beyond.
@en
P1433
P1476
Which sentinel lymph-node (SLN ...... OSOG Z0011 results and beyond.
@en
P2093
G Bruce Mann
Wolfgang Gatzemeier
P304
P356
10.1016/J.BREAST.2013.02.001
P577
2013-03-09T00:00:00Z